Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001)

Clinical trial NCT01974687 · COMPLETED

Trial details

NCT number: NCT01974687
Sponsor: Merck Sharp & Dohme LLC
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Chronic Hepatitis C

Start date: 2013-10-31
Primary completion: 2015-09-02
Enrollment: 178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.